The company’s AI-powered, scalable, and customized business process management solutions provide faster, more personalized customer…
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…
TOKYO, Jun 5, 2023 – (JCN Newswire) – TOYOTA GAZOO Racing World Rally Team driver…
New CHM 1101 (CLXT CAR T) multi-center clinical trial activated at Sarah Cannon Research Institute…
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Washington, D.C., Jun 5, 2023 – (ACN Newswire) – The Government Blockchain Association (GBA) honored…
Initiates Pre-Arranged Chapter 11 Process with Substantial Support from Lenders to Facilitate Comprehensive Balance Sheet…
MELBOURNE, Australia & SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Team Global Express, Australia and New Zealand’s leading multi-modal logistics…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), a global leader…
Relay2 brings 2X larger payload, customized accessories, and upgraded cloud-based elevator integration, enabling hotel owner/operators…
Overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69…
NEW YORK–(BUSINESS WIRE)–Massive Bio, a globally recognized leader in the oncology space, has proudly announced…
Further analyses from the Phase 1/1b CHRYSALIS-2 study showed patients with osimertinib pre-treated EGFR-mutated lung…
– Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in…
CHICAGO–(BUSINESS WIRE)–#biomarker—Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology,…
The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety…
Additional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX® (daratumumab) subcutaneous (SC)…
– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data…
BEERSE, BELGIUM, June 03, 2023 (GLOBE NEWSWIRE) — The Janssen Pharmaceutical Companies of Johnson &…
– Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily…